The receptor tyrosine kinase epidermal growth factor receptor (EGF-R) and its ligands are over expressed in pancreatic cancer tissues and in pancreatic cancer cell lines [2,3], with coexpression of receptor and ligand correlating with tumor invasiveness [4]. This evidence concerns the gene EGFR and neoplasm.